Curaleaf Holdings Inc
TSX:CURA
Gross Margin
Curaleaf Holdings Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Curaleaf Holdings Inc
TSX:CURA
|
1.5B CAD |
48%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
720.4B USD |
82%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
402.4B USD |
68%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
207.2B CHF |
74%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
176.2B GBP |
82%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
184B CHF |
76%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
84%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
205.7B USD |
78%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
135.4B USD |
75%
|
Curaleaf Holdings Inc
Glance View
Curaleaf Holdings Inc., a prominent player in the burgeoning cannabis market, has carved out a significant niche for itself by fully integrating its operations from cultivation to distribution. Founded in 2010, the Massachusetts-based company has rapidly grown to become one of the largest cannabis retailers in the United States. With a keen eye on the complex regulatory landscape, Curaleaf has strategically expanded its footprint across multiple states, adapting to various state laws and regulations. Their operational strategy hinges on vertical integration, meaning they control every stage of the cannabis supply chain. This allows Curaleaf not only to maintain high product quality and consistency but also to maximize margins by reducing costs and gaining efficiencies at all levels of production and retailing. Generating revenue through a combination of wholesale and retail sales, Curaleaf has established a range of products including cannabis flower, oils, edibles, and topical treatments, catering to both medical and recreational customers. The company's retail outlets, spanning across multiple states, are crucial in driving sales, where knowledgeable staff guide customers through intricate product offerings aimed at satisfying diverse consumer needs. Meanwhile, Curaleaf’s wholesale division supplies products to other retail outlets, expanding its market reach and solidifying its brand presence. The synergy between its retail prowess and wholesale operations has allowed Curaleaf to sustain steady revenue growth, positioning it well in a highly competitive and rapidly evolving industry.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Curaleaf Holdings Inc's most recent financial statements, the company has Gross Margin of 48.1%.
You don't have any saved screeners yet